SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015829
Filing Date
2020-11-06
Accepted
2020-11-05 18:12:26
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aeri-20200930.htm   iXBRL 10-Q 1491369
2 EX-31.1 aeri9302020ex311.htm EX-31.1 12467
3 EX-31.2 aeri9302020ex312.htm EX-31.2 12461
4 EX-32.1 aeri9302020ex321.htm EX-32.1 7299
5 EX-32.2. aeri9302020ex322.htm EX-32.2. 7243
  Complete submission text file 0001628280-20-015829.txt   6703551

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20200930.xsd EX-101.SCH 45015
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20200930_cal.xml EX-101.CAL 76040
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20200930_def.xml EX-101.DEF 218286
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20200930_lab.xml EX-101.LAB 575994
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20200930_pre.xml EX-101.PRE 361993
11 EXTRACTED XBRL INSTANCE DOCUMENT aeri-20200930_htm.xml XML 1153753
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 201291849
SIC: 2836 Biological Products, (No Diagnostic Substances)